AGORA Cancer Research Center

AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).

Latest news

News

Better Understanding the Fine Chemistry of Ovarian Cancer

Events

Ludwig Distinguished Lecture, Prof. Miriam Merad | April 2nd

More information

Events

PhD Thesis Defense | April 24th

More information

Events

Lola and John Grace Distinguished Lecture in Cancer Research, Prof. Sarah Teichmann | April 30th

More information

Events

2nd Symposium on AI for Clinical and Translational Medicine | May 6th

Register

Events

AGORA Single-cell omics meetings | May 6th

More information

Highlighted publication

The evolving landscape of brain metastasis: volume II

Valiente M, Anders C, Boire A, (…), Winkler F, Zadeh G, Joyce JA

Trends in Cancer – 2026 Feb 10

Highlighted publication

CCL3 is produced by aged neutrophils across cancers and promotes tumor growth

Bolli E, Wirapati P, Hicham M, (…), Mercier F, Manguso R, Pittet MJ

Cancer Cell – 2026 Feb 5

Highlighted publication

Hallmarks of cancer—Then and now, and beyond

Hanahan D

Cell – 2026 Jan 29

Highlighted publication

Tumor-derived aminopeptidase N promotes early stages of brain metastatic colonization.

Bejarano L, Hernández-Barranco A, Roh V, (…), Hegi ME, Fournier N, Joyce JA

Cell Reports – 2026 Feb 24

Events

AGORA PRS Seminar | March 31st

More information

Events

AGORA PRS Special Guest Seminar, Prof. Jean-Philippe Gratton | March 24th

More information

Past news

Latest publications

Bcl-xL blockade targets neutrophils and synergizeswith chemotherapy in lung squamous cell carcinoma.

Mayet A, Parma B, Lécuyer D, (…), Perentes JY, Oliver TG, Meylan E

EMBO Molecular Medicine – 2026 Mar 31

La-[(18/19)F]fluoride complexes: a novel addition to the radiofluorination family.

Behe M, Gruber S, Li C, (…), Mu L, Schottelius M, Faizova R

Dalton transactions – 2026 Mar 30

Nodal Upstaging and Oncologic Outcomes After Segmentectomy Versus Lobectomy for Early-Stage Non-Small Cell Lung Cancer.

Tudor A, Tian Y, Zanfrini E, (…), Perentes JY, Krueger T, Gonzalez M

Cancers – 2026 Mar 23

Is CXCR4 Theranostics in Oncologic, Cardiovascular, and Inflammatory Diseases Really Happening?

Hartrampf PE, Werner RA, Higuchi T, Schottelius M, Buck AK

Journal of nuclear medicine – 2026 Mar 12

Prognostic relevance and cytokine correlates of peripheral immune subpopulations in newly diagnosed glioblastoma.

Roncelli F, Snider S, Boselli D, (…), Villa C, Mortini P, Gagliardi F

Journal of neuro-oncology – 2026 Mar 7